User login
Reaching Out to Caregivers of Veterans With Dementia
Dietary Sodium Restriction in Veterans: A Modifiable Risk Factor for Chronic Disease
BEST PRACTICES IN: Managing Eczema With Natural Ingredients
A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company
• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA
Dr Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA
Dr Reyes Merin has nothing to disclose.
A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company
• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA
Dr Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA
Dr Reyes Merin has nothing to disclose.
A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company
• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA
Dr Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA
Dr Reyes Merin has nothing to disclose.
BEST PRACTICES IN: The Role of Copay Reduction Programs Within a Physician's Practice.
A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.
• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients
Faculty/Faculty Disclosure
Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ
Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.
Copyright © 2010 Elsevier Inc.
A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.
• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients
Faculty/Faculty Disclosure
Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ
Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.
Copyright © 2010 Elsevier Inc.
A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.
• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients
Faculty/Faculty Disclosure
Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ
Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.
Copyright © 2010 Elsevier Inc.
BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne
A supplement to Pediatric News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
A supplement to Pediatric News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
A supplement to Pediatric News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
The VHA's National Pain Management Strategy: Implementing the Stepped Care Model
Management of Patients With Amyotrophic Lateral Sclerosis
Updates in Specialty Care
BEST PRACTICES IN: Management of Patients With T2DM: The Risk and Role of Chronic Kidney Disease
A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
To view the supplement, click the image above.
Topics
- Epidemiology of CKD/RI With DM
- Risk Factors for CKD/RI in Patients With T2DM
- Early Identification and Screening
- CKD Strongly Effects CV Outcomes in Patients With DM
- Awareness of the Importance of CKD/RI Is Lacking
- CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
- Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD
Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL
Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ
Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.
Copyright © 2011 Elsevier Inc.
A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
To view the supplement, click the image above.
Topics
- Epidemiology of CKD/RI With DM
- Risk Factors for CKD/RI in Patients With T2DM
- Early Identification and Screening
- CKD Strongly Effects CV Outcomes in Patients With DM
- Awareness of the Importance of CKD/RI Is Lacking
- CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
- Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD
Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL
Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ
Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.
Copyright © 2011 Elsevier Inc.
A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
To view the supplement, click the image above.
Topics
- Epidemiology of CKD/RI With DM
- Risk Factors for CKD/RI in Patients With T2DM
- Early Identification and Screening
- CKD Strongly Effects CV Outcomes in Patients With DM
- Awareness of the Importance of CKD/RI Is Lacking
- CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
- Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD
Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL
Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ
Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.
Copyright © 2011 Elsevier Inc.
BEST PRACTICES IN: The Treatment of Heavy Menstrual Bleeding
A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.
To view the supplement, click the image above.
Topics
- Introduction
- Definition & Diagnosis
- Tranexamic Acid for the Treatment of HMB
- Conclusion
Faculty/Faculty Disclosure
Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois
Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.
Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan
Dr Rosenberg
Copyright © 2011 Elsevier Inc.
A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.
To view the supplement, click the image above.
Topics
- Introduction
- Definition & Diagnosis
- Tranexamic Acid for the Treatment of HMB
- Conclusion
Faculty/Faculty Disclosure
Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois
Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.
Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan
Dr Rosenberg
Copyright © 2011 Elsevier Inc.
A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.
To view the supplement, click the image above.
Topics
- Introduction
- Definition & Diagnosis
- Tranexamic Acid for the Treatment of HMB
- Conclusion
Faculty/Faculty Disclosure
Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois
Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.
Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan
Dr Rosenberg
Copyright © 2011 Elsevier Inc.